Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 May 15;101(10):2080–2091. doi: 10.1172/JCI1359

The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts.

J P Schanstra 1, E Bataillé 1, M E Marin Castaño 1, Y Barascud 1, C Hirtz 1, J B Pesquero 1, C Pecher 1, F Gauthier 1, J P Girolami 1, J L Bascands 1
PMCID: PMC508796  PMID: 9593764

Abstract

The bradykinin B1-receptor is strongly upregulated under chronic inflammatory conditions. However, the mechanism and reason are not known. Because a better understanding of the mechanism of the upregulation will help in understanding its potential importance in inflammation, we have studied the molecular mechanism of B1-receptor upregulation in cultured human lung fibroblasts (IMR 90) in response to IL-1beta and the B1-agonist [des-Arg10]-kallidin. We show that treatment of human IMR 90 cells by IL-1beta stimulates the expression of both B1-receptor mRNA and protein. The latter was studied by Western blot analysis using antipeptide antibodies directed against the COOH-terminal part of the human B1-receptor. We furthermore report the novel observation that the B1-receptor is upregulated by its own agonist which was completely blocked by the specific B1-antagonist [des-Arg10-Leu9]-kallidin, indicating an upregulation entirely mediated through cell surface B1-receptors. The increased population of B1-receptors was functionally coupled as exemplified by an enhancement of the B1-agonist induced increase in free cytosolic calcium. Upregulation by the B1-agonist was blocked by a specific protein kinase C inhibitor. B1-agonist-induced upregulation was correlated to the induction of transcription factor nuclear factor kappaB (NF-kappaB) which efficiently bound to the NF-kappaB-like sequence located in the promoter region of the human B1-receptor gene. This correlation was further confirmed by reporter gene assays which showed that this NF-kappaB-like sequence, in the B1-receptor promoter context, could contribute to IL-1beta and DLBK-induced B1-receptor transcription activation, and by the effect of NF-kappaB inhibitor pyrrolidinedithiocarbamate which diminished both B1-receptor upregulation and NF-kappaB activation. NF-kappaB is now recognized as a key inflammatory mediator which is activated by the B1-agonist but which is also involved in B1-receptor upregulation.

Full Text

The Full Text of this article is available as a PDF (466.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AbdAlla S., Godovac-Zimmermann J., Braun A., Roscher A. A., Müller-Esterl W., Quitterer U. Structure of the bradykinin B2 receptors' amino terminus. Biochemistry. 1996 Jun 11;35(23):7514–7519. doi: 10.1021/bi9601060. [DOI] [PubMed] [Google Scholar]
  2. Abraham W. M. The potential role of bradykinin antagonists in the treatment of asthma. Agents Actions Suppl. 1992;38(Pt 3):439–449. [PubMed] [Google Scholar]
  3. Austin C. E., Faussner A., Robinson H. E., Chakravarty S., Kyle D. J., Bathon J. M., Proud D. Stable expression of the human kinin B1 receptor in Chinese hamster ovary cells. Characterization of ligand binding and effector pathways. J Biol Chem. 1997 Apr 25;272(17):11420–11425. doi: 10.1074/jbc.272.17.11420. [DOI] [PubMed] [Google Scholar]
  4. Bachvarov D. R., Hess J. F., Menke J. G., Larrivée J. F., Marceau F. Structure and genomic organization of the human B1 receptor gene for kinins (BDKRB1). Genomics. 1996 May 1;33(3):374–381. doi: 10.1006/geno.1996.0213. [DOI] [PubMed] [Google Scholar]
  5. Baeuerle P. A., Baltimore D. NF-kappa B: ten years after. Cell. 1996 Oct 4;87(1):13–20. doi: 10.1016/s0092-8674(00)81318-5. [DOI] [PubMed] [Google Scholar]
  6. Barnes P. J., Adcock I. M. NF-kappa B: a pivotal role in asthma and a new target for therapy. Trends Pharmacol Sci. 1997 Feb;18(2):46–50. doi: 10.1016/s0165-6147(97)89796-9. [DOI] [PubMed] [Google Scholar]
  7. Bascands J. L., Pecher C., Rouaud S., Emond C., Tack J. L., Bastie M. J., Burch R., Regoli D., Girolami J. P. Evidence for existence of two distinct bradykinin receptors on rat mesangial cells. Am J Physiol. 1993 Mar;264(3 Pt 2):F548–F556. doi: 10.1152/ajprenal.1993.264.3.F548. [DOI] [PubMed] [Google Scholar]
  8. Bhoola K. D., Figueroa C. D., Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev. 1992 Mar;44(1):1–80. [PubMed] [Google Scholar]
  9. Blank V., Kourilsky P., Israël A. NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem Sci. 1992 Apr;17(4):135–140. doi: 10.1016/0968-0004(92)90321-y. [DOI] [PubMed] [Google Scholar]
  10. Cheng H. F., Becker B. N., Burns K. D., Harris R. C. Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest. 1995 May;95(5):2012–2019. doi: 10.1172/JCI117886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cheronis J. C., Whalley E. T., Allen L. G., Loy S. D., Elder M. W., Duggan M. J., Gross K. L., Blodgett J. K. Design, synthesis, and in vitro activity of bis(succinimido)hexane peptide heterodimers with combined B1 and B2 antagonist activity. J Med Chem. 1994 Feb 4;37(3):348–355. doi: 10.1021/jm00029a006. [DOI] [PubMed] [Google Scholar]
  12. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  13. Christiansen S. C., Proud D., Sarnoff R. B., Juergens U., Cochrane C. G., Zuraw B. L. Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):900–905. doi: 10.1164/ajrccm/145.4_Pt_1.900. [DOI] [PubMed] [Google Scholar]
  14. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983 Mar 11;11(5):1475–1489. doi: 10.1093/nar/11.5.1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Dinarello C. A. The interleukin-1 family: 10 years of discovery. FASEB J. 1994 Dec;8(15):1314–1325. [PubMed] [Google Scholar]
  16. Dixon B. S., Sharma R. V., Dennis M. J. The bradykinin B2 receptor is a delayed early response gene for platelet-derived growth factor in arterial smooth muscle cells. J Biol Chem. 1996 Jun 7;271(23):13324–13332. doi: 10.1074/jbc.271.23.13324. [DOI] [PubMed] [Google Scholar]
  17. Emond C., Bascands J. L., Rakotoarivony J., Praddaude F., Bompart G., Pecher C., Ader J. L., Girolami J. P. Glomerular B2-kinin-binding sites in two-kidney, one-clip hypertensive rats. Am J Physiol. 1991 May;260(5 Pt 2):F626–F634. doi: 10.1152/ajprenal.1991.260.5.F626. [DOI] [PubMed] [Google Scholar]
  18. Engelman D. M., Steitz T. A., Goldman A. Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins. Annu Rev Biophys Biophys Chem. 1986;15:321–353. doi: 10.1146/annurev.bb.15.060186.001541. [DOI] [PubMed] [Google Scholar]
  19. Ghosh S., Baltimore D. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature. 1990 Apr 12;344(6267):678–682. doi: 10.1038/344678a0. [DOI] [PubMed] [Google Scholar]
  20. Goldstein R. H., Wall M. Activation of protein formation and cell division by bradykinin and des-Arg9-bradykinin. J Biol Chem. 1984 Jul 25;259(14):9263–9268. [PubMed] [Google Scholar]
  21. Grynkiewicz G., Poenie M., Tsien R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985 Mar 25;260(6):3440–3450. [PubMed] [Google Scholar]
  22. Hall J. M. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol Ther. 1992 Nov;56(2):131–190. doi: 10.1016/0163-7258(92)90016-s. [DOI] [PubMed] [Google Scholar]
  23. Hepler J. R., Kozasa T., Smrcka A. V., Simon M. I., Rhee S. G., Sternweis P. C., Gilman A. G. Purification from Sf9 cells and characterization of recombinant Gq alpha and G11 alpha. Activation of purified phospholipase C isozymes by G alpha subunits. J Biol Chem. 1993 Jul 5;268(19):14367–14375. [PubMed] [Google Scholar]
  24. Hess J. F., Borkowski J. A., Young G. S., Strader C. D., Ransom R. W. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Commun. 1992 Apr 15;184(1):260–268. doi: 10.1016/0006-291x(92)91187-u. [DOI] [PubMed] [Google Scholar]
  25. Hollinger M. A. Effect of endotoxin on mouse serum angiotensin-converting enzyme. Am Rev Respir Dis. 1983 Jun;127(6):756–757. doi: 10.1164/arrd.1983.127.6.756. [DOI] [PubMed] [Google Scholar]
  26. Lalmanach G., Hoebeke J., Moreau T., Ferrer-Di Martino M., Gauthier F. An immunochemical approach to investigating the mechanism of inhibition of cysteine proteinases by members of the cystatin superfamily. J Immunol Methods. 1992 May 18;149(2):197–205. doi: 10.1016/0022-1759(92)90251-n. [DOI] [PubMed] [Google Scholar]
  27. MacNeil T., Bierilo K. K., Menke J. G., Hess J. F. Cloning and pharmacological characterization of a rabbit bradykinin B1 receptor. Biochim Biophys Acta. 1995 Nov 7;1264(2):223–228. doi: 10.1016/0167-4781(95)00152-7. [DOI] [PubMed] [Google Scholar]
  28. Marceau F. Kinin B1 receptors: a review. Immunopharmacology. 1995 Jun;30(1):1–26. doi: 10.1016/0162-3109(95)00011-h. [DOI] [PubMed] [Google Scholar]
  29. Margolius H. S. Theodore Cooper Memorial Lecture. Kallikreins and kinins. Some unanswered questions about system characteristics and roles in human disease. Hypertension. 1995 Aug;26(2):221–229. doi: 10.1161/01.hyp.26.2.221. [DOI] [PubMed] [Google Scholar]
  30. McEachern A. E., Shelton E. R., Bhakta S., Obernolte R., Bach C., Zuppan P., Fujisaki J., Aldrich R. W., Jarnagin K. Expression cloning of a rat B2 bradykinin receptor. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7724–7728. doi: 10.1073/pnas.88.17.7724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. McIntyre P., Phillips E., Skidmore E., Brown M., Webb M. Cloned murine bradykinin receptor exhibits a mixed B1 and B2 pharmacological selectivity. Mol Pharmacol. 1993 Aug;44(2):346–355. [PubMed] [Google Scholar]
  32. Menke J. G., Borkowski J. A., Bierilo K. K., MacNeil T., Derrick A. W., Schneck K. A., Ransom R. W., Strader C. D., Linemeyer D. L., Hess J. F. Expression cloning of a human B1 bradykinin receptor. J Biol Chem. 1994 Aug 26;269(34):21583–21586. [PubMed] [Google Scholar]
  33. Nukiwa T., Matsuoka R., Takagi H., Ishii Y., Arai T., Kira S. Responses of serum and lung angiotensin-converting enzyme activities in the early phase of pulmonary damage induced by oleic acid in dogs. Am Rev Respir Dis. 1982 Dec;126(6):1080–1086. doi: 10.1164/arrd.1982.126.6.1080. [DOI] [PubMed] [Google Scholar]
  34. Nwator I. A., Whalley E. T. Angiotensin converting enzyme inhibitors and expression of des-Arg9-BK (kinin B1) receptors in vivo. Eur J Pharmacol. 1989 Jan 24;160(1):125–132. doi: 10.1016/0014-2999(89)90661-4. [DOI] [PubMed] [Google Scholar]
  35. Pan Z. K., Zuraw B. L., Lung C. C., Prossnitz E. R., Browning D. D., Ye R. D. Bradykinin stimulates NF-kappaB activation and interleukin 1beta gene expression in cultured human fibroblasts. J Clin Invest. 1996 Nov 1;98(9):2042–2049. doi: 10.1172/JCI119009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Persson B., Argos P. Prediction of transmembrane segments in proteins utilising multiple sequence alignments. J Mol Biol. 1994 Mar 25;237(2):182–192. doi: 10.1006/jmbi.1994.1220. [DOI] [PubMed] [Google Scholar]
  37. Pesquero J. B., Pesquero J. L., Oliveira S. M., Roscher A. A., Metzger R., Ganten D., Bader M. Molecular cloning and functional characterization of a mouse bradykinin B1 receptor gene. Biochem Biophys Res Commun. 1996 Mar 7;220(1):219–225. doi: 10.1006/bbrc.1996.0384. [DOI] [PubMed] [Google Scholar]
  38. Polosa R., Holgate S. T. Comparative airway response to inhaled bradykinin, kallidin, and [des-Arg9]bradykinin in normal and asthmatic subjects. Am Rev Respir Dis. 1990 Dec;142(6 Pt 1):1367–1371. doi: 10.1164/ajrccm/142.6_Pt_1.1367. [DOI] [PubMed] [Google Scholar]
  39. Polosa R., Rajakulasingam K., Prosperini G., Milazzo L. V., Santonocito G., Holgate S. T. Cross-tachyphylactic airway response to inhaled bradykinin, kallidin and [desArg9]-bradykinin in asthmatic subjects. Eur Respir J. 1993 May;6(5):687–693. [PubMed] [Google Scholar]
  40. Praddaude F., Tack I., Emond C., Bascands J. L., Girolami J. P., Tran-Van T., Regoli D., Ader J. L. In vivo and in vitro homologous desensitization of rat glomerular bradykinin B2 receptors. Eur J Pharmacol. 1995 Dec 27;294(1):173–182. doi: 10.1016/0014-2999(95)00532-3. [DOI] [PubMed] [Google Scholar]
  41. Regoli D., Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol Rev. 1980 Mar;32(1):1–46. [PubMed] [Google Scholar]
  42. Rice C. L., Kohler J. P., Casey L., Szidon J. P., Daise M., Moss G. S. Angiotensin-converting enzyme (ACE) in sepsis. Circ Shock. 1983;11(1):59–63. [PubMed] [Google Scholar]
  43. Schreck R., Baeuerle P. A. A role for oxygen radicals as second messengers. Trends Cell Biol. 1991 Aug;1(2-3):39–42. doi: 10.1016/0962-8924(91)90072-h. [DOI] [PubMed] [Google Scholar]
  44. Smrcka A. V., Hepler J. R., Brown K. O., Sternweis P. C. Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq. Science. 1991 Feb 15;251(4995):804–807. doi: 10.1126/science.1846707. [DOI] [PubMed] [Google Scholar]
  45. Starr S., Kozell L. B., Neve K. A. Drug-induced up-regulation of dopamine D2 receptors on cultured cells. J Neurochem. 1995 Aug;65(2):569–577. doi: 10.1046/j.1471-4159.1995.65020569.x. [DOI] [PubMed] [Google Scholar]
  46. Stewart J. M. Bradykinin antagonists: development and applications. Biopolymers. 1995;37(2):143–155. doi: 10.1002/bip.360370208. [DOI] [PubMed] [Google Scholar]
  47. Taylor S. J., Chae H. Z., Rhee S. G., Exton J. H. Activation of the beta 1 isozyme of phospholipase C by alpha subunits of the Gq class of G proteins. Nature. 1991 Apr 11;350(6318):516–518. doi: 10.1038/350516a0. [DOI] [PubMed] [Google Scholar]
  48. Thanos D., Maniatis T. NF-kappa B: a lesson in family values. Cell. 1995 Feb 24;80(4):529–532. doi: 10.1016/0092-8674(95)90506-5. [DOI] [PubMed] [Google Scholar]
  49. Thomas R. F., Holt B. D., Schwinn D. A., Liggett S. B. Long-term agonist exposure induces upregulation of beta 3-adrenergic receptor expression via multiple cAMP response elements. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4490–4494. doi: 10.1073/pnas.89.10.4490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Tippmer S., Quitterer U., Kolm V., Faussner A., Roscher A., Mosthaf L., Müller-Esterl W., Häring H. Bradykinin induces translocation of the protein kinase C isoforms alpha, epsilon, and zeta. Eur J Biochem. 1994 Oct 1;225(1):297–304. doi: 10.1111/j.1432-1033.1994.00297.x. [DOI] [PubMed] [Google Scholar]
  51. Waldo G. L., Boyer J. L., Morris A. J., Harden T. K. Purification of an AlF4- and G-protein beta gamma-subunit-regulated phospholipase C-activating protein. J Biol Chem. 1991 Aug 5;266(22):14217–14225. [PubMed] [Google Scholar]
  52. abu Alla S., Quitterer U., Grigoriev S., Maidhof A., Haasemann M., Jarnagin K., Müller-Esterl W. Extracellular domains of the bradykinin B2 receptor involved in ligand binding and agonist sensing defined by anti-peptide antibodies. J Biol Chem. 1996 Jan 19;271(3):1748–1755. doi: 10.1074/jbc.271.3.1748. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES